Muscle, Skeletal
7
2
2
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (7)
Prebiotic Inulin for Late-Reproductive Individuals
STAY-STRONG Study of Exercise Training During Chemotherapy
Distinct Sources of Supplementary Protein in the Resistance Exercise Training-induced Adaptations
Cancer-associated Muscle Mass - Molecular Factors and Exercise Mechanisms
Comparison of Different Forms of Recovery on the Functionality After Physical Exercise
Whey Protein Support to Metabolic and Performance Adaptations in Response HIIT
Protein Ingestion and Muscle Carnitine Uptake